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Abstract
Background: Oxidative stress due to excessive production of reactive oxygen species (ROS) and subsequent lipid
peroxidation plays a critical role in renal ischemia/reperfusion (IR) injury. The purpose of current study is to demonstrate the
effect of antecedent ethanol exposure on IR-induced renal injury by modulation of oxidative stress.
Materials and Methods: Bilateral renal warm IR was induced in male C57BL/6 mice after ethanol or saline administration.
Blood ethanol concentration, kidney function, histological damage, inflammatory infiltration, cytokine production, oxidative
stress, antioxidant capacity and Aldehyde dehydrogenase (ALDH) enzymatic activity were assessed to evaluate the impact
of antecedent ethanol exposure on IR-induced renal injury.
Results: After bilateral kidney ischemia, mice preconditioned with physiological levels of ethanol displayed significantly
preserved renal function along with less histological tubular damage as manifested by the reduced inflammatory infiltration
and cytokine production. Mechanistic studies revealed that precondition of mice with physiological levels of ethanol 3 h
before IR induction enhanced antioxidant capacity characterized by significantly higher superoxidase dismutase (SOD)
activities. Our studies further demonstrated that ethanol pretreatment specifically increased ALDH2 activity, which then
suppressed lipid peroxidation by promoting the detoxification of Malondialdehyde (MDA) and 4-hydroxynonenal (HNE).
Conclusions: Our results provide first line of evidence indicating that antecedent ethanol exposure can provide protection
for kidneys against IR-induced injury by enhancing antioxidant capacity and preventing lipid peroxidation. Therefore,
ethanol precondition and ectopic ALDH2 activation could be potential therapeutic approaches to prevent renal IR injury
relevant to various clinical conditions.
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Introduction
Ischemia/reperfusion (IR), a common pathological process,
occurs under various clinical conditions such as trauma, hypo-
volemic shock, sepsis, and most importantly renal transplantation.
Surgical procedures requiring cross clamping of the aorta and
renal vessels are associated with a renal failure rate up to 30% [1],
and only a mild increase in the serum creatinine levels (0.3–
0.4 mg/dl) is associated with a 70% greater risk of death [2]. In
renal transplantation, the IR injury not only contributes to the
early functional failure or delayed function for the grafts, but also
strongly increases the incidence of both acute and chronic
rejection, and therefore, it dampens the long-term graft survival.
Given the fact that organ shortage has forced the compromise of
using organs from expanded criteria of donors, which renders the
renal grafts subject to more severely IR injury [3]. Therefore, the
need for additional therapeutic modalities to prevent renal IR
injury is quite urgent.
The pathophysiology of renal IR injury includes both direct
cellular damage caused by ischemic insult, and delayed dysfunc-
tion/damage due to the activation of inflammatory pathways [4].
Since inflammatory response is a sequential event, it would be
more relevant to block the initial signal [5,6,7,8]. Oxidative stress,
a common event caused by excessive production of reactive
oxygen species (ROS) during IR process, is a critical factor
implicated in both direct and subsequent cellular damage [9,10].
Indeed, antioxidant therapy has already been shown to be
protective against IR-mediated oxidative damage in different
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most important sources of oxidative stress, and previous studies
have already demonstrated evidence indicating its implication in
renal IR injury [13,14]. It is an autocatalytic mechanism resulting
in oxidative destruction of cellular membranes associated with the
production of toxic, reactive aldehydic metabolites and cell death
[15]. Malondialdehyde (MDA) and 4-hydroxynonenal (HNE) are
the most important aldehydic metabolites. Excessive production of
these highly cytotoxic metabolites would cause their diffusion from
the site of origin to attack distant targets, through which they form
covalent links with various molecules (adducts) to mediate the
inactivation of enzymes and inhibition of DNA, RNA and protein
syntheses.
The deleterious effects of lipid peroxidation might be prevented
by enhancing the scavenging systems. Indeed, studies in cardiac
ischemia suggested that pretreatment with physiological levels of
ethanol can provide cardioprotection, which is consistently
correlated with the phosphorylation status of Aldehyde Dehydro-
genase 2 (ALDH2), a key metabolic enzyme in the oxidation and
detoxification of reactive aldehydes in a range of organs and cell
types [16,17]. ALDH2 is a mitochondrial enzyme, belonging to
the ALDH gene family. ALDH2 not only catalyzes the oxidation
of acetaldehyde to acetic acid in ethanol metabolism, but also acts
as a key metabolic enzyme involved in the detoxification of other
reactive aldehydes such as HNE [18]. Other than cardiac IR
injury, the protective effect of antecedent ethanol exposure has
also been proved in the brain and intestine IR injury [19,20,21].
However, virtually no information is available regarding to its role
in IR-induced renal damage. Given the fact that consumption of
red wine at low to moderate levels is beneficial for renal disease
and ethanol pretreatment prevents postischemic leukocyte-endo-
thelial cell adhesive interactions that is critical for inflammatory
infiltration after IR, we therefore hypothesized that pretreatment
with physiological levels of ethanol would protect kidneys against
IR injury by modulating antioxidant capability and preventing
lipid peroxidation.
Materials and Methods
Animals and ethics statement
Male C57BL/6 mice (8–12 wk, weight 20–25 g) were obtained
from Joint Ventures Sipper BK Experimental Animal (Shanghai,
China). All animal experiments were performed in accordance
with the guidelines of National Institute of Health for the Care and
Use of Laboratory Animals, and approved by the Scientific
Investigation Board of Second Military Medical University,
Shanghai, China.
Induction of renal IR
Mice were anesthetized with sodium pentobarbital (i.p., 50 mg/
kg). After a midline laparotomy, renal pedicles on both sides were
closed for 30 min with nontraumatic microaneurysm clamps
(Shanghai Medical Instruments, Shanghai, China). The inci-
sion was temporarily closed during ischemia. The abdomen was
closed after visual verification of reperfusion upon the removal of
microaneurysm clamps. Mice with sham surgery (no interruption
of the renal blood flow) were used as controls. Body temperature
was maintained with an adjustable heating pad at 37uC. All mice
were i.p. injected with 500 ml 0.9% NaCl upon completion of the
surgery, and were sacrificed 24 h or day 7 after reperfusion. At the
time of sacrifice, blood was collected through inferior vena cava
into a heparinized syringe for plasma biochemistry within 24 h.
Kidneys were fixed in 10% neutral-buffered formalin for paraffin
embedding or snap frozen for later use. Some mice were housed
individually in metabolism cages in the first 24 h after reperfusion
for collection of urine samples. For ethanol pretreatment, mice
were injected different dose of ethanol (0.25, 0.5, 1, 2 g/kg body
weight) before the induction of kidney IR. The control group
received the largest volume of saline as that in the 2 g/kg body
weight dose group.
Primary culture of mouse renal tubular epithelial cells
and simulated IR
Primary mouse renal tubular epithelial cells (TEC) were
cultured following a method described by Wuthrich et al. [22].
Briefly, kidneys were flushed in situ with 0.9% NaCl to remove
blood. The outer cortex was cut into pieces of approximately
1m m
3, and digested in HBSS containing 1 mg/ml of collagenase
type 1 (Worthington) at 37uC for 30 min and washed through a
sieve (mesh diameter 75 mm) in DMEM/F12 medium (Invitrogen)
to obtain single cell suspensions. After centrifugation at 300 g for
5 min, the pellet was resuspended in DMEM/F12 medium
supplemented with 1% penicillin/streptomycin and 10% FCS
(Invitrogen), and incubated at 37uC for 3 h in a Petri dish to allow
contaminated glomerular cells to adhere. The non-adherent
tubular cells were next collected and cultured in 6 - well plates
in DMEM/F12 medium supplemented with 10% FCS until
epithelial colonies were established. TECs were identified by
cobblestone-shaped morphology and expression of cytokeratin 18
(CK18) using an anti-CK18 antibody (Santa Cruz) as described by
Wu et al. [23]. Tubular cells prepared as above showed .95% of
purity.
IR was simulated by immersing cell monolayer in mineral oil as
previously described [24]. In brief, TECs were starved in serum-
free (SF) DMEM/F12 medium for 24 h. After washes with PBS,
the cells were immersed in mineral oil (Sigma-Aldrich) for 60 min
at 37uC. After extensive washes with PBS, the cells were incubated
in DMEM/F12 medium supplemented with 10% FCS, and
subjected to functional analysis 24 h after medium replacement.
Assessment of renal function
Plasma creatinine (PCr), urea, sodium (PNa), urine creatinine
(UCr) and sodium (UNa) were assessed using a standard
autoanalyzer at the Central Laboratory, Changzheng Hospital,
Shanghai. Urinary osmolality (UOsm) was measured using an
automatic freezing point osmometer (L1590031, Xiyu Electrical
and Mechanical Systems, Inc., Shanghai, China). Fractional
excretion of sodium (FENa, %) was calculated from the standard
formula FENa=P Cr6UNa6100/(UCr6PNa).
Measurement of oxidation
Thiobarbituric acid-reactive substances (Sigma) were employed
to assess lipid peroxidation. Samples were evaluated for MDA
production via a spectrophotometric assay for thiobarbituric acid-
reactive substances [25,26]. The amount of SOD activity from
renal homogenates was measured with a commercial SOD assay
kit (Cayman Chemical, Ann Arbor, MI). Hydroxynonenal (HNE)
concentration was determined using fresh cytosolic fractions with
the method described by Esterbauer et al [27]. An aliquot of
cytosol (200 ml) was extracted using equal volume of acetic acid/
acetonitrile solution (4 : 96, vol : vol). After centrifugation at 250 g
for 20 min at 4uC, 50 ml of supernatant were injected into a high-
performance liquid chromatography (HPLC) Symmetry C18
column (5 mm, 3.96150 mm). The mobile phase used was
acetonitrile:bidistilled water (42%, vol : vol). The HNE concen-
tration was calculated based on a standard concentration curve
(Calbiochem-Novabiochem Corp., La Jolla, CA, USA).
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Kidneys embedded in paraffin were sectioned at 2 mm and
stained with H&E by standard methods. Tubular damage was
estimated using a grading scale of 0–4, as outlined by Jablonski et
al. [28] Three representative sections from each kidney were
scored. At least 10 high-power fields (6400) per section were
examined for each sample. Histological examination was per-
formed by two pathologists in a blinded fashion.
Real-time RT-PCR analysis
Total kidney RNA was extracted using TRIzol (Invitrogen)
reagent according to the manufacturer’s instructions. cDNA was
synthesized using oligo d(T) (Applied Biosystems) and a Super-
Script III Reverse Transcriptase Kit (Invitrogen). A StepOne
TM
Real-Time PCR System (Applied Biosystems) and a SYBR RT-
PCR kit (Takara) were used for quantitative real-time RT-PCR
analysis. All reactions were conducted in a 20 ml reaction volume
in triplicate. The relative expression levels for a target gene were
normalized by GAPDH. Specificity was verified by melting curve
analysis and agarose gel electrophoresis. Primers used RT-PCR
analysis are: TNF-a (59-AAG CCT GTA GCC CAC GTC GTA-
39;5 9-GGC ACC ACT AGT TGG TTG TCT TTG-39); IL-6 (59-
ACA ACC ACG GCC TTC CCT ACT T-39;5 9-CAC GAT
TTC CCA GAG AAC ATG TG-39); IL-8 (59-ATG CCC TCT
ATT CTG CCA GAT-39;5 9-GTG CTC CGG TTG TAT AAG
ATG AC-39); IL-10 (59-GCT CTTA CTG ACT GGC ATG AG-
39;5 9-CGC AGC TCT AGG AGC ATG TG-39); CD3 (59-AGA
GGG CAA AAC AAG GAG CG-39;5 9-AGA CTG CTC TCT
GAT TCA GGC-39); CD11b (59-ATG GAC GCT GAT GGC
AAT ACC-39;5 9-TCC CCA TTC ACG TCT CCC A-39); iNOS
(59- ACA TCG ACC CGT CCA CAG TAT -39;5 9- CAG AGG
GGT AGG CTT GTC TC-39); eNOS (59-TCA GCC ATC ACA
GTG TTC CC-39;5 9- ATA GCC CGC ATA GCG TAT CAG-
39); and GAPDH (59-TGA CCA CAG TCC ATG CCA TC-39;
59-GAC GGA CAC ATT GGG GGT AG-39). Data were
analyzed using the comparative Ct (2
2DDCt) method.
ELISA and renal MPO activity assay
For measurement of myeloperoxidase (MPO) activity in renal
homogenates, kidneys were homogenized in a buffer containing
50 mM Tris–HCl, 1 mM EDTA and 5% Sucrose (pH 7.4). The
detailed steps were in accordance with manufacturer’s protocol of
the kit (Jiancheng Bioengineering Institute, Nanjing, China). MPO
activity was expressed as DOD per minute per milligram total
protein in renal lysates.
Immunoblot analysis
Snap-frozen renal tissues or cultured cells were lysed with the M-
PER Protein Extraction Reagent (Pierce) supplemented with a
protease inhibitor ‘cocktail’. The samples were incubated for 30 min
at 4uC and centrifuged at 16,000 g at 4uC for 15 min. Lysates were
collected and stored at 270uC until use. Protein concentration in the
lysates was measured with a bicinchoninic acid assay (Pierce). Equal
amount of lysates were separated by SDS-PAGE, and then transferred
onto nitrocellulose membranes for immunoblot analysis.
Measurement of ethanol concentration in the plasma
Ready-to-use Q.E.D. A150 Alcohol Test kit (OraSure Technologies,
Bethlehem, PA) was used to quantify alcohol levels in the plasma samples.
Assay for ALDH enzymatic activity
Enzymatic activity for ALDH was determined spectrophoto-
metrically by monitoring the reductive reaction of NAD
+ to
NADH at 340 nm as previously described [16,17,29]. ALDH2
assays were carried out at 25uC in 50 mM sodium pyrophosphate
buffer (pH=9.5). The reaction includes 10 mM acetaldehyde and
400 mg of lysate protein isolated from kidneys. The accumulation
of NADH was monitored for 5 min with measurements being
taken every 30 s after addition of 2.5 mM NAD. ALDH reactive
rates were expressed as mmol NADH/min/mg protein.
Knockdown of ALDH2 in TECs
Mouse primary cultured TECs were transfected with a negative
control siRNA (NC) or an ALDH2-siRNA, using the INTER-
FERin
TM transfection reagent (Polyplus). TECs treated with the
INTERFERin
TM transfection reagent only were served as another
negative control. The assays were conducted 48 h after transfec-
tion.
Measurement of lactate dehydrogenase release
Lactate dehydrogenase (LDH) in the culture medium and
primary renal TECs was measured using the modified colorimetric
routine laboratory method [30]. Briefly, culture supernatants or
cell lysates were incubated with 0.2 mmol/l b-NADH and
0.4 mmol/l pyruvic acid diluted in PBS (pH 7.4). It was also
confirmed that addition of ethanol to the incubation mixture did
not alter the oxidation of b-NADH. LDH concentration in the
sample was proportional to the linear decrease in the absorbance
at 334 nm, and calculated using a commercial standard. The
percentage of LDH released from primary renal TECs was
calculated as LDH present in culture supernatant in relation to
total LDH obtained in the culture medium and primary renal
TECs.
Statistics
Data from multiple groups were analyzed using one way
ANOVA with post-hoc Bonferroni’s correction (GraphPad Prism
5.0; GraphPad Software). Data derived from two groups were
analyzed using an unpaired Student’s t test or a Mann - Whitney
test (two tailed). All data were expressed as mean 6 SEM. In all
cases, p,0.05 was considered with statistical significance.
Results
1. Blood ethanol concentration
We first monitored the temporal blood ethanol concentration
after intra-peritoneal (i. p.) injection. To this end, the mice were i.p.
injected with 5% ethanol at a dose of 1 g/kg body weight. The
mice were next sacrificed at indicated time point and ethanol
concentration in the plasma was determined as described. As
shown in Figure 1, high levels of ethanol can be detected as early
as 15 min after i.p. injection, and the highest level (approximately
51 mg/dl or 11 mM) was observed 30 min after injection, which
is equivalent to the physiologically attainable blood ethanol levels
in humans after one to three drinks [31,32]. The blood ethanol
then underwent a steady decrease and 3 h after injection returned
to the level as controls. Together, our data demonstrated a similar
result as that obtained using the gastric ingestion approach
[19,20].
2. Ethanol pretreatment protects kidneys against IR injury
To assess the effect of ethanol pretreatment on renal IR injury,
we administered mice with different doses of ethanol, and 3 h later
the mice were subjected to induction of bilateral renal IR injury.
It was interestingly noted that antecedent ethanol exposure
dose-dependently protected kidneys against IR-induced injury
(Figure 2A). The strongest protective effect was observed when
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creatinine decreased by 72.8% as compared with that of mice
administrated with normal saline. However, for those doses above
1 g/kg such as 2 g/kg failed to provide a significant protective
effect. Therefore, 1 g/kg is likely the most optimal dose for
mediating the protective effect.
Next, we injected mice with 1 g/kg of ethanol, followed by
induction of those mice with bilateral renal IR injury at
indicated time point. The protective effect was noted as early
as 1 h after ethanol administration and lasted until 24 h
post ethanol administration as manifested by the lower plas-
ma creatinine and urea (Figure 2B). Particularly, the most
prominent protective effect was observed 3 h after ethanol
administration, in which the amount of plasma creatinine and
urea was only about 30.4% and 58.8% as that of control mice,
respectively. We further assessed tubular function by measuring
the fractional excretion of sodium (FENa)a n du r i n eo s m o l a l i t y
(UOsm). Ethanol pretreatment significantly decreased FENa but
increased urine osmolality as compared with that of controls
(Figure 2C & 2D).
In line with the above results, histological analysis of renal
sections 24 h and day 7 after IR induction revealed that an-
tecedent ethanol exposure reduced tubular injury as characterized
by less tubular necrosis, less severity for loss of the brush border
and cast formation (Figure 3A). The Jablonski index further
confirmed the protective effect of antecedent ethanol exposure in
IR-induced tubular damage (Figure 3B).
We then assessed the intra kidney inflammatory infiltration by
RT-PCR analysis. We first examined CD11b and CD3
expression, the two critical markers for myeloid cells and T cells,
respectively. It was noted that CD11b and CD3 were significantly
increased in the kidneys 24 h after reperfusion. On the other
hand, Pretreatment of mice with 1 g/kg of ethanol reduced
CD11b mRNA by 56.3% and CD3 mRNA by 55.9% (Figure 4A).
Next, we performed MPO assay to assess the severity of
neutrophil infiltration, and similar results were obtained
(Figure 4B). Given the fact that cytokines such as TNF-a,I L - 6 ,
IL-8 and IL-10 play critical roles in IR-induced renal injury, we
therefore further compared their expressions between ethanol
treated mice and control mice. Interestingly, mRNAs for TNF-a,
IL-6 and IL-8 were significantly higher in control mice as
compared with that of ethanol treated mice. In sharp contrast,
IL-10 was significantly higher in ethanol treated mice 24 h after
IR induction (Figure 4C).
3. Ethanol pretreatment decreased IR-induced oxidative
stress in the kidneys
To dissect the underlying mechanisms by which antecedent
ethanol exposure protects kidneys against IR-induced injury, we
first examined oxidative stress in the kidneys of mice treated with
either ethanol or saline by measuring MDA production and HNE
concentration. It was interestingly noted that the production of
MDA and the concentration of HNE in the kidneys originated
from mice with antecedent ethanol exposure were significantly
lower as compared with that of control mice (Figure 5A & 5B),
demonstrating that antecedent ethanol exposure inhibits
IR-induced oxidative stress in the kidneys. To demonstrate
whether the reduced oxidative stress relevant to ethanol
pretreatment is associated with enhanced antioxidant capacity,
we next examined SOD activity, the critical enzyme responsible
for detoxifying ROS. As expected, kidneys originated from mice
with antecedent ethanol exposure showed significantly higher
SOD activity after IR induction as compared with that of control
mice (Figure 5C), suggesting that ethanol pretreatment enhanced
antioxidant capability. We further determined the expression of
inducible nitric oxide synthase (iNOS) and endothelial nitric oxide
synthase (eNOS) in the kidneys after IR insult. As shown in
Figure 5D, both iNOS and eNOS were induced 24 h post
reperfusion. However, ethanol pretreatment enhanced much
higher iNOS expression as compared with that of controls.
Kinetic studies revealed that the potency for inducing iNOS
expression was much stronger at 24 h post reperfusion than that of
earlier time points such as 1–6 h after ethanol exposure
(Figure 5E).
4. Ethanol pretreatment enhanced ALDH2 activity to
prevent IR-induced lipid peroxidation
As lipid peroxidation due to excessive generation of MDA and
HNE plays a critical role in IR-induced renal injury, the above
results prompted us to further examine the impact of antecedent
ethanol exposure on lipid peroxidation after IR induction. For this
purpose, we checked the enzymatic activity of ALDH, a family of
metabolic enzymes involved in both ethanol metabolism and
reactive aldehydes such as HNE detoxification. It was noted that
ethanol administration itself did not show a significant impact on
ALDH activities (Figure 6A). However, when mice were
pretreated with ethanol, the ALDH activities were significantly
higher upon IR induction, and a 1 - fold increase was observed 1 h
after reperfusion (Figure 6B). Given the fact that kidneys express
multiple ALDH isozymes such as ALDH2, ALDH3a1, ALDH3a2,
ALDH4a1, ALDH7a1 and ALDH8a1, we tried to document
changes in gene transcription and protein expression for each
isozyme, but failed to get any significant results between saline
and ethanol pretreated mice (data not shown). As ALDH2 has
been proved to be a key metabolic enzyme involved in both
ethanol metabolism and the detoxification of other reactive
aldehydes such as HNE, we next sought to determine whether
ALDH2 plays a predominant role of the protection induced by
ethanol pretreatment. To this end, we performed immunopre-
cipitation with antibody against ALDH2 to separate the total
protein from renal lysates into the ALDH2-enriched immuno-
Figure 1. Plasma ethanol concentrations in mice after ethanol
administration. Mice received an i.p. injection of 5% ethanol at a dose
of 1 g/kg body weight were sacrificed at indicated time after, and
plasma ethanol concentration were assayed. The CTR group did not
receive any ethanol. Results are mean values 6 SEM (n=4–6). (* p,0.05,
** p,0.01, *** p,0.001; in comparison with the CTR group).
doi:10.1371/journal.pone.0025811.g001
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our expectation, ALDH activities were significantly higher in
ethanol pretreated mice as compared with control mice in
ALDH2-enriched immunoprecipitates resulted from the same
amount of renal lysates. Particularly, when ALDH2 was depleted,
both ethanol pretreated and control mice showed similar ALDH
activities (Figure 6C & 6D). Altogether, our results suggest that
antecedent ethanol exposure before IR insult increases ALDH2
Figure 2. Ethanol pretreatment preserved kidney function after renal IR. A. Mice were pretreated with saline or ethanol at different dose. A
30 min bilateral renal ischemia was induced 3 h later. Blood samples were harvested at 24 h after reperfusion to assess the plasma creatinine and
urea. Sham controls underwent the same procedure without vascular occlusion. Results are mean values 6 SEM (n=4–8). B. Mice were pretreated
with ethanol (1 g/kg) and exposed to a 30 min bilateral renal ischemia after different time interval. Blood samples were harvested at 24 h after
reperfusion to assess the plasma creatinine and urea. Results are mean values 6 SEM (n=5–6). C. & D. Mice were pretreated with saline or 1 g/kg
ethanol, and were exposed to a 30-min bilateral renal IR 3 h later. FENa and Uosm were assessed at 24 h after reperfusion. (* p,0.05, ** p,0.01,
*** p,0.001, in comparison with saline control of that group (sham or IR) for A., and with the 15 min group for B.).
doi:10.1371/journal.pone.0025811.g002
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peroxidation.
5. Knock-down of ALDH2 expression abrogated the
protective effect of ethanol pretreatment on renal IR
injury
To further confirm the above results, we employed an in vitro
simulation IR model in primary renal TECs. We first
confirmed that ethanol pretreatment (50 mM) of TECs 3 h
before simulated IR reduced LDH release (Figure 7A). Next, an
ALDH2 specific siRNA was transfected into the primary renal
TECs, which resulted in an 82.1% decrease for ALDH2 protein
levels 48 h after transfection as manifested by Western blotting
(Figure 7B) followed by densitometric analysis (Figure 7C).
Consistently, the ALDH enzymatic activities were decreased by
67.3% (Figure 7D). Importantly, when the same protocol of
ethanol pretreatment and simulated IR was applied in the
ALDH2 siRNA transfected cells, the protective effect induced
by ethanol pretreatment was almost completely abrogated
(Figure 7E).
Discussion
Although the protective effect for consumption of alcoholic
beverages at low to moderate levels (1–3 drinks/day for months to
years) have been widely documented in cardiovascular diseases
[33,34,35], less investigation is done in its relation to the kidney
diseases [36]. Previous studies revealed that long-term alcohol
abuse is associated with many renal alterations in humans [37],
but moderate amount of red wine for diabetic patients is suggested
to be helpful for slowing down the progression of diabetic
nephropathy [38]. Experimental studies paid more attention to the
polyphenols in the wine and found that they could enhance renal
antioxidant defense [39,40] and inhibit mesangial cell apoptosis
[41,42], through which red wines were suggested to protect
kidneys against IR injury [43,44]. The exact effect of ethanol on
renal IR injury, however, remains poorly elucidated [36].
The present studies for the first time demonstrated that
moderate ethanol administration antecedent to renal IR induction
provides protection in a dose and time dependent manner. After
bilateral renal ischemia, ethanol pretreated mice displayed
significantly preserved renal function as characterized by less
Figure 3. Ethanol pretreatment attenuated tubular damage after renal IR. Mice were pretreated with saline or 1 g/kg ethanol, and were
exposed to a 30-min bilateral renal IR 3 h later. Kidney samples were collected at 24 h post reperfusion and assessed for: A. H&E staining of renal
outer medulla (left panel) and cortex (right panel). Sections are representative of 6–8 independent mice per experimental group (2006 original
magnification). B. Scoring of the tubular injury according to the Jablonski’s criteria. (* p,0.05, ** p,0.01).
doi:10.1371/journal.pone.0025811.g003
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proinflammatory cytokine production. We further demonstrated
that the protective effect was associated with ameliorated oxidative
stress as manifested by the increase of antioxidant capacity (higher
SODactivities) and decrease of lipid peroxidation(less generationof
MAD and HNE). Further studies revealed that ethanol adminis-
tration antecedent to IR insult significantly enhanced the enzymatic
activity of ALDH2, which then promoted the detoxification of
aldehydic metabolites to prevent lipid peroxidation. By employing
an in vitro IR simulation model, we confirmed that the protective
effect of antecedent ethanol exposure on IR-induced renal injury
dependent on the induction of ALDH2. Transfection of a siRNA
specific for ALDH2 into the primary cultured TECs completely
abrogated the protective effect. Taken together, our data de-
monstrate that moderate antecedent ethanol exposure provides
protection for kidneys against subsequent IR-induced injury by
increasing antioxidant capacity and by preventing lipid peroxida-
tion through increasing the activity of ALDH2.
Our data presented in the current report are in agreement with
previous studies in the heart, intestine and brain after IR induction
[16,17,19,20,45]. Using an intestine IR model, Yamaguchi et al.
demonstrated that single bolus ethanol ingestion markedly
attenuated IR induced increases in leukocyte rolling and adhesion
[20]. They reported a biphasic temporal pattern of protection
against the proinflammatory effects, which included the early
phase at 2–3 h and the late phase at 24 h post ethanol
pretreatment, and suggested that the late phase of ethanol
pretreatment is triggered by NO formed secondary to adenosine
Figure 4. Ethanol pretreatment attenuated inflammation after renal IR. Mice were pretreated with saline or 1 g/kg ethanol, and were
exposed to a 30-min bilateral renal IR 3 h later. Kidney samples were collected at 24 h post reperfusion and assessed for: A. CD11b, CD3 mRNA
expression; B. MPO activity; and C. TNF-a, IL-6, IL-8 and IL-10 mRNA expression. Results are mean values 6 SEM. (n=4–6). (* p,0.05, ** p,0.01,
*** p,0.001).
doi:10.1371/journal.pone.0025811.g004
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ethanol exposure. In another brain IR injury model, a late phase
(24 h) protection against neurodegenerative processes was also
observed in moderate ethanol ingested mice, and an NADPH
oxidase dependent triggering mechanism was reported to be
critically involved [19].
Interestingly, we observed a similar biphasic protection against
renal IR injury in ethanol antecedent exposed mice, but more
powerful in the early phase at 3 h after ethanol pretreatment. We
ruled out the possibility that differences in approaches for ethanol
administration might affect the results, as we observed almost the
same peak levels of ethanol in the blood and same elimination
kinetics as compare with that in precious studies [19,20]. Similar
to the studies of LPS pretreatment [46], we found that ethanol
pretreatment enhanced iNOS rather than eNOS expression after
IR insult. Our kinetic studies further suggest that the capacity to
enhance iNOS expression at 24 h post reperfusion was higher at
the late phase (i.e.,24 h) in comparison with that at the earlier
phases (e.g.,1–6 h) after ethanol pretreatment. These results
suggest that the enhanced iNOS expression may be responsible
for the late phase protection conferred by ethanol pretreatment.
However, further studies using iNOS or eNOS deficient mice
Figure 5. Ethanol pretreatment ameliorated oxidative stress after renal IR. Mice were pretreated with saline or 1 g/kg ethanol, and were
exposed to a 30-min bilateral renal IR 3 h later. Kidney samples were collected at 24 h post reperfusion for assay of: A. MDA levels; B. HNE levels; and
C. SOD activities; and D. iNOS & eNOS expression. E. Mice were pretreated with saline or ethanol (1 g/kg) and exposed to a 30-min bilateral renal
ischemia after different time interval. Kidney samples were collected at 24 h post reperfusion for assay of iNOS & eNOS expression. Results are mean
values 6 SEM. (n=4–6). (* p,0.05, ** p,0.01).
doi:10.1371/journal.pone.0025811.g005
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system on ethanol-induced protection in renal IR injury.
The early phase (60 min) effect of ethanol pretreatment
was extensively studied in the cardiac IR model [17]. The
predominant role in mediating cytoprotection was suggested to be
attributed to ALDH2, an intra-mitochondrial enzyme involved in
the detoxification of toxic aldehydes such as HNE [16,29]. In line
with this result, we found that the early phase protection in our
model was also associated with markedly elevated ALDH
enzymatic activity in the kidneys. Our in vitro studies demon-
strated that the early phase protection was ALDH2 dependent
since knockdown of ALDH2 by siRNA abrogated the protective
effect.
To rule out that direct chemical stimulation due to high
concentration of ethanol might affect the results, we kept constant
ethanol concentration at 5%. Therefore, the total saline volumes
among each ethanol dose groups were different, and the control
group received the largest volume of saline as that in the 2 g/kg
body weight dose group. Nevertheless, the volumes of saline
before kidney IR induction did not show a perceptible effect on
the response to IR injury, as we failed to observe any difference
on the renal function after IR insult between the mice injected
with or without saline at the largest volume (data not shown).
Despite that better renal function was observed based on the
histological results in the kidneys of ethanol-pretreated mice at
day 7 post reperfusion, we cannot exclude the possibility that the
well reserved renal function was due to that ethanol treatment
accelerated the recovery of renal function after IR insult. As such,
further studies would be necessary with focus on to verify whether
ethanol pretreatment accelerates renal functional recovery. It is
noteworthy that pretreatment with high dose of ethanol (2 g/Kg)
failed to protect the animals against IR injury. Given our
observations that the predominant protective effect occurs in the
short-term period (i.e., 3 h), the protective effect for the high dose
of ethanol could be overwhelmed by its damaging impact on the
kidneys that concomitantly occurs within the same window of
time period. As a consequence, additional mechanistic studies
would be important to clarify the narrow therapeutic window for
ethanol pretreatment in the prevention of IR-induced renal
injury.
In summary, our data resulted from a renal IR model provide
the first line of experimental evidence for the effect of antecedent
ethanol exposure by single bolus i.p. injection on biphasic
protection of kidneys against IR-induced injury, with much
stronger protective effect observed 3 h after ethanol administration
(early phase). Moreover, our work suggests that the protective
effect is ALDH2 dependent, which serves as a key enzyme in
eliminating the toxic aldehydes produced by IR to prevent lipid
peroxidation. Altogether, our results demonstrate that moderate
ethanol ingestion and ectopic ALDH2 activation could be viable
therapeutic approaches for various clinical conditions involving
renal IR injury.
Figure 6. Ethanol pretreatment increased ALDH2 enzymatic activity after renal IR. A. Mice were pretreated with 1 g/kg ethanol and
kidney samples were collected for ALDH enzymatic activity assay at different time after ethanol exposure. The CTR group did not receive any ethanol.
B. Mice were pretreated with saline or 1 g/kg ethanol, and were exposed to a 30-min bilateral renal IR 3 h later. Kidney samples were collected at
different time after reperfusion. C. Immunoprecipitation was performed to separate the total protein from kidney tissues to the ALDH2-enriched part
(ALDH2-IP), and the ALDH2-depleted part (ALDH2-DE). D. ALDH enzymatic assay was performed in the ALDH2 enriched or depleted proteins. Results
are mean values 6 SEM. (n=4–5). (* p,0.05, ** p,0.01).
doi:10.1371/journal.pone.0025811.g006
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